• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Navigating axillary staging post-neoadjuvant systemic therapy: innovations, efficacy, and oncologic safety.

作者信息

Wazir Umar, Mokbel Kefah

机构信息

The London Breast Institute, Princess Grace Hospital, London, UK.

出版信息

Gland Surg. 2024 Jun 30;13(6):1146-1149. doi: 10.21037/gs-24-125. Epub 2024 Jun 26.

DOI:10.21037/gs-24-125
PMID:39015695
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11247578/
Abstract
摘要

相似文献

1
Navigating axillary staging post-neoadjuvant systemic therapy: innovations, efficacy, and oncologic safety.新辅助全身治疗后腋窝分期的探索：创新、疗效及肿瘤学安全性
Gland Surg. 2024 Jun 30;13(6):1146-1149. doi: 10.21037/gs-24-125. Epub 2024 Jun 26.
2
MINImal vs. MAXimal Invasive Axillary Staging and Treatment After Neoadjuvant Systemic Therapy in Node Positive Breast Cancer: Protocol of a Dutch Multicenter Registry Study (MINIMAX).新辅助全身治疗后腋窝阳性乳腺癌的最小化与最大化侵袭性分期和治疗：荷兰多中心注册研究方案（MINIMAX）。
Clin Breast Cancer. 2022 Jan;22(1):e59-e64. doi: 10.1016/j.clbc.2021.07.011. Epub 2021 Jul 26.
3
Patterns of axillary staging and management in clinically node positive breast cancer patients treated with neoadjuvant systemic therapy: Results of a survey amongst breast cancer specialists.新辅助全身治疗后临床淋巴结阳性乳腺癌患者腋窝分期和管理模式：乳腺癌专家调查结果。
Eur J Surg Oncol. 2020 Jan;46(1):53-58. doi: 10.1016/j.ejso.2019.08.012. Epub 2019 Aug 13.
4
Axillary Management of Stage II/III Breast Cancer in Patients Treated with Neoadjuvant Systemic Therapy: Results of CALGB 40601 (HER2-Positive) and CALGB 40603 (Triple-Negative).接受新辅助全身治疗的II/III期乳腺癌患者的腋窝管理：CALGB 40601（HER2阳性）和CALGB 40603（三阴性）的研究结果
J Am Coll Surg. 2017 Apr;224(4):688-694. doi: 10.1016/j.jamcollsurg.2016.12.036. Epub 2017 Jan 13.
5
Feasibility and safety of targeted axillary dissection guided by intraoperative ultrasound after neoadjuvant treatment.新辅助治疗后术中超声引导下靶向腋窝清扫术的可行性和安全性。
Eur J Surg Oncol. 2023 Oct;49(10):106938. doi: 10.1016/j.ejso.2023.05.013. Epub 2023 May 22.
6
Evaluating Radar Reflector Localisation in Targeted Axillary Dissection in Patients Undergoing Neoadjuvant Systemic Therapy for Node-Positive Early Breast Cancer: A Systematic Review and Pooled Analysis.评估新辅助全身治疗的淋巴结阳性早期乳腺癌患者在靶向腋窝清扫术中雷达反射器定位：一项系统评价和汇总分析
Cancers (Basel). 2024 Mar 29;16(7):1345. doi: 10.3390/cancers16071345.
7
De-Escalating Axillary Surgery in Node-Positive Breast Cancer Treated with Neoadjuvant Systemic Therapy.新辅助全身治疗的淋巴结阳性乳腺癌患者腋窝手术的降阶梯治疗
Breast Care (Basel). 2021 Dec;16(6):584-589. doi: 10.1159/000518376. Epub 2021 Aug 17.
8
Major Reduction in Axillary Lymph Node Dissections After Neoadjuvant Systemic Therapy for Node-Positive Breast Cancer by combining PET/CT and the MARI Procedure.新辅助全身治疗联合 PET/CT 和 MARI 操作后，腋窝淋巴结清扫术在阳性乳腺癌患者中的大量减少。
Ann Surg Oncol. 2018 Jun;25(6):1512-1520. doi: 10.1245/s10434-018-6404-y. Epub 2018 Mar 6.
9
A novel nomogram containing efficacy indicators to predict axillary pathologic complete response after neoadjuvant systemic therapy in breast cancer.一种包含疗效指标的新型列线图，可预测乳腺癌新辅助全身治疗后的腋窝病理完全缓解。
Front Endocrinol (Lausanne). 2022 Nov 25;13:1042394. doi: 10.3389/fendo.2022.1042394. eCollection 2022.
10
Evaluating Magnetic Seed Localization in Targeted Axillary Dissection for Node-Positive Early Breast Cancer Patients Receiving Neoadjuvant Systemic Therapy: A Comprehensive Review and Pooled Analysis.评估新辅助全身治疗的淋巴结阳性早期乳腺癌患者在靶向腋窝清扫中磁性种子定位：一项综述与汇总分析
J Clin Med. 2024 May 14;13(10):2908. doi: 10.3390/jcm13102908.

引用本文的文献

1
Comparison of targeted axillary dissection with sentinel node biopsy alone on nodal recurrence for patients who have node-positive breast cancer treated with neoadjuvant chemotherapy: a critical appraisal.新辅助化疗治疗的淋巴结阳性乳腺癌患者，靶向腋窝清扫与单纯前哨淋巴结活检在淋巴结复发方面的比较：一项批判性评估。
Gland Surg. 2025 Jun 30;14(6):1171-1173. doi: 10.21037/gs-2025-152. Epub 2025 Jun 26.

本文引用的文献

1
Evaluating Magnetic Seed Localization in Targeted Axillary Dissection for Node-Positive Early Breast Cancer Patients Receiving Neoadjuvant Systemic Therapy: A Comprehensive Review and Pooled Analysis.评估新辅助全身治疗的淋巴结阳性早期乳腺癌患者在靶向腋窝清扫中磁性种子定位：一项综述与汇总分析
J Clin Med. 2024 May 14;13(10):2908. doi: 10.3390/jcm13102908.
2
Omission of Axillary Dissection Following Nodal Downstaging With Neoadjuvant Chemotherapy.新辅助化疗后淋巴结降期时省略腋窝清扫术。
JAMA Oncol. 2024 Jun 1;10(6):793-798. doi: 10.1001/jamaoncol.2024.0578.
3
Evaluating Radar Reflector Localisation in Targeted Axillary Dissection in Patients Undergoing Neoadjuvant Systemic Therapy for Node-Positive Early Breast Cancer: A Systematic Review and Pooled Analysis.
评估新辅助全身治疗的淋巴结阳性早期乳腺癌患者在靶向腋窝清扫术中雷达反射器定位：一项系统评价和汇总分析
Cancers (Basel). 2024 Mar 29;16(7):1345. doi: 10.3390/cancers16071345.
4
Systematic review of targeted axillary dissection in node-positive breast cancer treated with neoadjuvant systemic therapy: variation in type of marker and timing of placement.新辅助全身治疗治疗阳性淋巴结乳腺癌的靶向腋窝清扫术的系统评价：标记物类型和放置时间的变化。
Br J Surg. 2024 Mar 2;111(3). doi: 10.1093/bjs/znae071.
5
Targeted axillary dissection: worldwide variations in clinical practice.目标腋窝清扫术：全球临床实践中的差异。
Breast Cancer Res Treat. 2024 Apr;204(2):389-396. doi: 10.1007/s10549-023-07204-7. Epub 2024 Jan 4.
6
Treatment of residual disease following neoadjuvant therapy in breast cancer.新辅助治疗后乳腺癌残留疾病的治疗。
J Surg Oncol. 2024 Jan;129(1):18-25. doi: 10.1002/jso.27523. Epub 2023 Nov 22.
7
Safety of Targeted Axillary Dissection After Neoadjuvant Therapy in Patients With Node-Positive Breast Cancer.新辅助治疗后腋窝淋巴结阳性乳腺癌患者行靶向腋窝清扫术的安全性。
JAMA Surg. 2023 Aug 1;158(8):807-815. doi: 10.1001/jamasurg.2023.1772.
8
Clinical feasibility and oncological safety of non-radioactive targeted axillary dissection after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: a prospective diagnostic and prognostic study.新辅助化疗后活检证实淋巴结阳性乳腺癌非放射性靶向腋窝清扫的临床可行性和肿瘤安全性：一项前瞻性诊断和预后研究。
Int J Surg. 2023 Jul 1;109(7):1863-1870. doi: 10.1097/JS9.0000000000000331.
9
Diagnostic Accuracy of Radioactive Iodine Seed Placement in the Axilla With Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Node-Positive Breast Cancer.新辅助化疗后前哨淋巴结活检中腋窝放射性碘种子埋置对阳性淋巴结乳腺癌的诊断准确性。
JAMA Surg. 2022 Nov 1;157(11):991-999. doi: 10.1001/jamasurg.2022.3907.
10
Three-year follow-up of de-escalated axillary treatment after neoadjuvant systemic therapy in clinically node-positive breast cancer: the MARI-protocol.新辅助全身治疗后临床淋巴结阳性乳腺癌降阶梯腋窝处理的 3 年随访：MARI 方案。
Breast Cancer Res Treat. 2022 May;193(1):37-48. doi: 10.1007/s10549-022-06545-z. Epub 2022 Mar 3.